Sobre la Empresa
- Nombre legal: Chengdu Climb Pharmaceutical Technology Co., Ltd.
- Nombre internacional: 成都克莱蒙医药科技有限公司 (Chengdu Climb Pharmaceutical Technology Co., Ltd.), Chengdu, Sichuan, China
- Marca / Nombre comercial: Climb
- País de registro: China
- Dirección: Room 909-911, Building C1, No. 88 Keyuan South Road, Tianfu Life Science & Technology Park, Gaoxin District, Chengdu 610041, Sichuan, China • Sichuan
- Año de fundación: 2013
Descripción:
Chengdu Climb Pharmaceutical Technology Co., Ltd., established in 2013, manufactures and trades active pharmaceutical ingredients and pharmaceutical intermediates and fine chemicals for markets worldwide. The company offers contract manufacturing services and is recognized for its international approvals, experienced R&D staff, production capacity and quality service.
Actividades Comerciales
Ingredientes Farmacéuticos Activos (API)
ProveedorFabricante de Principios Activos (API)Fabricante
Formas Farmacéuticas Terminadas
Fabricante
Servicios de contratación y externalización
Proveedor de Servicios
Mercados de Venta
- East Asia: China, Democratic People's Republic of Korea, Republic of Korea, Japan
- Western Asia: Cyprus
- Northern Europe: Denmark, Finland, Iceland, Ireland, Norway, Sweden, United Kingdom
- Southern Europe: Andorra, Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain, Vatican City
- Western Europe: Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, Netherlands, Switzerland
Productos/Servicios Clave
- Ingredientes Farmacéuticos Activos (API): Palbociclib, Etoricoxib, Active Pharmaceutical Ingredients, Brivaracetam, Avibactam Sodium, Apixaban, Vinpocetine, Parecoxib Sodium, Rupatadine fumarate, Macitentan, Moxifloxacin hydrochloride, Anacetrapib, Anamorelin, AZD9291, Cinacalcet HCl, Desvenlafaxine succinate, Macimorelin Acetate, Parecoxib Sodium cas:197502-82-2, Phenylethyl caffeate, ROLAPITANT, Tirofiban hydrochloride monohydrate
- Formas Farmacéuticas Terminadas: Lactulose oral solution, Finished antibiotic medicines
- Químicos Farmacéuticos: Active Pharmaceutical Ingredients, Pharmaceutical Intermediates, (R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol, 6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one, (S,S)-2,8-Diazabicyclo[4,3,0]nonane, Vincamine, 1-(6-Methylpyridin-3-yl)-2-[4(methylsulfonyl)phenyl]ethanone, 4-Methylsulfonyl phenyl acetic acid, 1-(6-methylpyridin-3-yl)-2-(4-(methylthio)phenyl)ethanone, 10,10-dimethylanthrone, 2-Chloro-1,3-bis(dimenthylamino)trimethinium hexafluorophosphate, 2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3d] pyrimidine-6-carboxamide, 2'-(Chloromethyl)-4-fluoro-5-isopropyl-2-Methoxy-4'- (trifluoroMethyl)-1,1'-biphenyl, 2-(trifluoromethyl)pyridin -4-amine, 2,4-dichloro-6-(6-(trifluoromethyl)pyridin -2-yl)-1,3,5-triazine, (2S,5R)- 5-(benzyloxyamino)piperidine -2-carboxamide, (2S,5R)-5-[(benzyloxy)amino]piperidine -2-carboxylic acid benzyl ester ethanedioate, (2s,5r)-5-((phenylmethoxy)amino) -2-piperidinecarboxylic acid ethyl ester ethanedioate, (2S,5R)-benzyl 5-(benzyloxyamino)piperidine -2-carboxylate, 3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone, 3-(Chloromethyl)-5-methylpyridine, (3R)-3-(Phenylmethyl)-3-piperidinecarboxylic acid trimethylhydrazide, 4-(4-Chlorobutyl)pyridine hydrochloride, 4-[6-[(6-Bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7- oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridin, 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate, 4'-FLUORO-2'-METHOXY-5'-ISOPROPYL-4-TRIFLUOROMETHYL-1,1'-BIPHENYL-2-METHANOL, 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo- 1H-pyrazolo[3,4-c]pyridine-3-carboxy, (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl] -4-methyl-1,3-oxazolidin- 2-one, 5-(4-Bromophenyl)-4,6-dichloropyrimidine, 5-Bromo-2-chloropyrimidine, 5-hydroxy-4-propyl-2(5H)-furanone, 5-Methyl-3,4-diphenyl- Isoxazole, 6-Benzofurancarboxylic acid, 6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-, hydrochloride, Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate, Methyl-6-methylnicotinate, methyl 6-(trifluoromethyl)picolinate, N-[2-Chloro-3-bis(dimethylamino)trimethinium, N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine, N-Butylsulfonyl-L-tyrosine, N-Propyl-sulfamide potassium salt, N-Propyl-sulfamide sodium salt, N-Propylsulfamide, N1-[2-(diMethylaMino)ethyl] -5-Methoxy-N1-Methyl-N4-[4-(1- Methyl-1H-indol-3-yl)-2-pyriMidinyl]benze, (R)-1-(1-(bromomethoxy)ethyl) -3,5-bis(trifluoromethy l)benzene, (R)-Dihydro-4-propyl-2(3H)-furanone, Rucaparib, Tabersonine, VALDECOXIB
- Clasificación ATC (Anatómica, Terapéutica, Química): Desloratadine
Nuestros Productos & Servicios
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
![(2S,5R)-5-[(benzyloxy)amino]piperidine -2-carboxylic acid benzyl ester ethanedioate](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F2s5r-5-benzyloxyaminopiperidine--2-carbo-78005.jpg&w=640&q=75)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
![Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fethyl-chloro4-methoxyphenylhydrazonoacet-78013.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
![N1-[2-(diMethylaMino)ethyl] -5-Methoxy-N1-Methyl-N4-[4-(1- Methyl-1H-indol-3-yl)-2-pyriMidinyl]benze](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fn1-2-dimethylaminoethyl--5-methoxy-n1-me-78016.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario